Overview
Cleft lip/palate-ectodermal dysplasia syndrome (also known as Zlotogora-Ogur syndrome or Margarita Island ectodermal dysplasia) is a rare genetic disorder characterized by the combination of orofacial clefting and features of ectodermal dysplasia. This condition affects multiple body systems derived from the ectoderm, including the skin, hair, nails, teeth, and sweat glands, along with structural abnormalities of the lip and palate. Key clinical features include cleft lip with or without cleft palate, sparse and dry hair (hypotrichosis), abnormal or missing teeth (hypodontia or oligodontia), nail dystrophy, and syndactyly (fusion of fingers or toes) in some cases. Affected individuals may also exhibit dry skin and reduced ability to sweat (hypohidrosis), which can lead to heat intolerance. The severity of symptoms can vary considerably among affected individuals, even within the same family. Treatment is symptomatic and multidisciplinary. Surgical repair of cleft lip and palate is typically performed in infancy or early childhood. Dental management, including prosthetic devices and orthodontic care, is important for addressing tooth abnormalities. Dermatologic care may be needed for skin and hair issues, and patients with hypohidrosis should take precautions to avoid overheating. Genetic counseling is recommended for affected families. There is currently no cure or disease-modifying therapy available for this condition.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsNational Cancer Institute (NCI) — PHASE2
RenJi Hospital — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Cleft lip/palate-ectodermal dysplasia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cleft lip/palate-ectodermal dysplasia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cleft lip/palate-ectodermal dysplasia syndrome.
Community
No community posts yet. Be the first to share your experience with Cleft lip/palate-ectodermal dysplasia syndrome.
Start the conversation →Latest news about Cleft lip/palate-ectodermal dysplasia syndrome
Disease timeline:
New recruiting trial: Target-specific immunoPET Imaging of Digestive System Carcinoma
A new clinical trial is recruiting patients for Cleft lip/palate-ectodermal dysplasia syndrome
New recruiting trial: Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
A new clinical trial is recruiting patients for Cleft lip/palate-ectodermal dysplasia syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cleft lip/palate-ectodermal dysplasia syndrome
What is Cleft lip/palate-ectodermal dysplasia syndrome?
Cleft lip/palate-ectodermal dysplasia syndrome (also known as Zlotogora-Ogur syndrome or Margarita Island ectodermal dysplasia) is a rare genetic disorder characterized by the combination of orofacial clefting and features of ectodermal dysplasia. This condition affects multiple body systems derived from the ectoderm, including the skin, hair, nails, teeth, and sweat glands, along with structural abnormalities of the lip and palate. Key clinical features include cleft lip with or without cleft palate, sparse and dry hair (hypotrichosis), abnormal or missing teeth (hypodontia or oligodontia),
How is Cleft lip/palate-ectodermal dysplasia syndrome inherited?
Cleft lip/palate-ectodermal dysplasia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Cleft lip/palate-ectodermal dysplasia syndrome typically begin?
Typical onset of Cleft lip/palate-ectodermal dysplasia syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Cleft lip/palate-ectodermal dysplasia syndrome?
2 specialists and care centers treating Cleft lip/palate-ectodermal dysplasia syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.